Genoil (GNOLF) Common Equity (2009 - 2025)

Genoil (GNOLF) has reported Common Equity for 16 consecutive years, with -$508876.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Common Equity fell 56.64% year-over-year to -$508876.0 in Q4 2025; TTM through Dec 2025 was -$508876.0, a 56.64% decrease from a year earlier, with the FY2025 full-year figure at -$508876.0, down 56.64% from the prior year.
• Common Equity was -$508876.0 for Q4 2025 at Genoil, up from -$538229.0 in the prior quarter.
• Over five years, Common Equity peaked at $349783.0 in Q2 2023 and troughed at -$11.1 million in Q1 2023.
• A 5-year average of -$2.5 million and a median of -$246025.5 in 2024 frame the typical range for Common Equity.
• The widest YoY moves for Common Equity: up 103.9% in 2023, down 3953.26% in 2023.
• Over 5 years, Common Equity stood at -$9.0 million in 2021, then retreated by 21.56% to -$11.0 million in 2022, then surged by 98.77% to -$135320.0 in 2023, then slumped by 140.08% to -$324875.0 in 2024, then sank by 56.64% to -$508876.0 in 2025.
• The last three Common Equity figures came in at -$508876.0 (Q4 2025), -$538229.0 (Q3 2025), and -$453610.0 (Q2 2025), per Business Quant data.